StockWatch
·
HomeLiveReports
Pharmaceuticals
Board Meeting28 Oct 2026, 12:29 pm

SMS Pharmaceuticals Board Meeting on Nov 4 to Approve Q2 FY27 Results

AI Summary

SMS Pharmaceuticals Ltd has announced that its Board of Directors will convene on Wednesday, November 4, 2026, to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the second quarter and half year ended September 30, 2026. The company has also informed about the closure of the trading window for its equity shares from October 1, 2026, to November 6, 2026, inclusive, in accordance with SEBI regulations.

Key Highlights

  • Board meeting scheduled for November 4, 2026.
  • To approve Q2 and H1 FY27 financial results.
  • Results will be standalone and consolidated.
  • Trading window closure announced.
  • Trading window reopens on November 7, 2026.
View BSE Filing
SMSPHARMA
Pharmaceuticals
SMS PHARMACEUTICALS LTD.

Price Impact

More from SMSPHARMA

Insider Trading24 Sept, 10:15 pm

SMS Pharmaceuticals Closes Trading Window for Q2/H1 FY27

AGM/EGM4 Sept, 3:48 pm

SMS Pharma Dispatches Annual Report, Sets AGM for Sep 29

Corporate Governance4 Sept, 11:58 am

SMS Pharmaceuticals Ltd Files BRSR for FY 2025-26

More in Board Meeting

MERCURYLAB14m ago

Mercury Laboratories Board Meeting on Nov 5 to Approve Unaudited Results

TCMLMTD15m ago

TCM Ltd Board Meeting on Nov 6 to Approve Q2 FY27 Results

EKANSH31m ago

Ekansh Concepts Board Meeting on Nov 5 to Approve Q2 FY27 Results